Sign in

Private company

NVN Liquidation, Inc.

NVN Liquidation, Inc. is an American pharmaceutical preparations company, incorporated in Delaware.1 It is headquartered in Pittsboro, North Carolina.1

Last updated Oct 21, 2026.

Overview

  • IndustryPharmaceutical Preparations1
  • HeadquartersPittsboro, North Carolina1
  • Incorporated inDE2
  • Business addressP.O. Box 64, Pittsboro, Nc 273122
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-144.5%Operating margin3
-132.2%Net margin3
700.6%Revenue growth, 20223
-679.9%Return on equity3
-$35.2MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue13¢$7.4M
  • Research and development27¢$16.0M
  • Selling, general and admin58¢$34.1M
  • Interest2¢$1.5M

Out of $23.7M in revenue.3 The company lost money this year.

Financial statements

Revenue4563$23.7M in 2022+795% since 2017
0$10.0M$20.0M$30.0M2017: $2.6M$2.6M20172018: $6.0M$6.0M2018+126%2019: $4.9M$4.9M2019−18%2020: $4.9M$4.9M2020+0%2021: $3.0M$3.0M2021−40%2022: $23.7M$23.7M2022+701%
Operating income748563-$34.2M in 2022−43% since 2016
-$60.0M-$40.0M-$20.0M02016: -$59.8M-$59.8M20162017: -$35.7M-$35.7M2017−40%2018: -$28.6M-$28.6M2018−20%2019: -$30.7M-$30.7M2019+7%2020: -$30.2M-$30.2M2020−2%2021: -$29.9M-$29.9M2021−1%2022: -$34.2M-$34.2M2022+14%
Net income748563-$31.3M in 2022−48% since 2016
-$60.0M-$40.0M-$20.0M02016: -$59.7M-$59.7M20162017: -$36.6M-$36.6M2017−39%2018: -$29.2M-$29.2M2018−20%2019: -$30.4M-$30.4M2019+4%2020: -$29.3M-$29.3M2020−4%2021: -$29.7M-$29.7M2021+1%2022: -$31.3M-$31.3M2022+5%
Fiscal year2016201720182019202020212022
Revenue$2.6M4$6.0M4$4.9M5$4.9M6$3.0M3$23.7M3
Cost of revenue$03$7.4M3
Research and development$46.5M7$25.2M4$23.0M8$25.2M5$19.8M6$20.4M3$16.0M3
Selling, general and admin$12.3M3$34.1M3
Operating expenses$32.9M6$57.9M3
Operating income-$59.8M7-$35.7M4-$28.6M8-$30.7M5-$30.2M6-$29.9M3-$34.2M3
Interest$2.0K12$1.0M4$1.0M8$2.0K5$05$03$1.5M3
Income tax$07$04$08$05$06$03$03
Net income-$59.7M7-$36.6M4-$29.2M8-$30.4M5-$29.3M6-$29.7M3-$31.3M3
Earnings per share-$2.966-$1.743-$1.423
Earnings per share (diluted)-$2.966-$1.743-$1.423
Shares (weighted, basic)17.1M shares322.0M shares3
Shares (weighted, diluted)17.1M shares322.0M shares3

Compare NVN Liquidation, Inc. with another company

What it owns

What NVN Liquidation, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$16.6M3 Dec 31, 2022$13.8M3 Dec 31, 2021+20.4%
Accumulated depreciation$2.7M3 Dec 31, 2022$1.6M3 Dec 31, 2021+71.2%
Property and equipment, net$13.9M3 Dec 31, 2022$12.2M3 Dec 31, 2021+13.8%
Operating-lease assets (leased space)$1.8M3 Dec 31, 2022$1.7M3 Dec 31, 2021+3.7%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$12.3M3 Dec 31, 2022$47.1M3 Dec 31, 2021−73.8%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$4.1M3 Dec 31, 2022$03 Dec 31, 2021
Intangible assets, net (excluding goodwill)$27.5M3 Dec 31, 2022$75.0K3 Dec 31, 2021+36533.3%
Accumulated amortization$1.6M3 Dec 31, 2022
Finite-lived intangibles, net$27.4M3 Dec 31, 2022

Inventory

ItemLatestA year beforeChange
Inventory, total$1.2M3 Dec 31, 2022$03 Dec 31, 2021
Finished goods$2.0M3 Dec 31, 2022

Leadership

Who has led NVN Liquidation, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Nathan Stasko2016
  2. G. Kelly Martin2017–2019
  3. Paula B. Stafford2020–2022

President

  1. Nathan Stasko2016–2018
  2. Paula B. Stafford2019–2022

Chief financial officer

  1. Richard D. Peterson2016
  2. William L. Hodges2017
  3. Jeff N. Hunter2018
  4. John M. Gay2021–2023

Chief operating officer

  1. Paula B. Stafford2019
  2. A. Donofrio John2022–2023
20202025
Board members and other officers (16)

Former names

  • Novan, Inc.Jul 2, 2009 to Sep 27, 20232

Timeline

  1. May 1, 20248-K Bankruptcy or receivership; Change to shareholders' rights; Executive or director change37
  2. Mar 25, 20248-K Regulation FD disclosure38
  3. Feb 26, 20248-K Regulation FD disclosure39
  4. Jan 30, 20248-K Bankruptcy or receivership; Change to shareholders' rights40
  5. Jan 26, 20248-K Regulation FD disclosure41
  6. Dec 21, 20238-K Regulation FD disclosure42
  7. Nov 22, 20238-K Regulation FD disclosure43
  8. Oct 24, 20238-K Regulation FD disclosure44
  9. Oct 20, 20238-K Bylaws or fiscal year changed45
  10. Sep 27, 20238-K Regulation FD disclosure46
  11. Sep 27, 20238-K Completed an acquisition or sale47
  12. Sep 27, 20238-K Completed an acquisition or sale; Executive or director change48
  13. Feb 4, 2020New chief executive Paula B. Stafford becomes CEO13
  14. Jun 7, 2017New chief executive G. Kelly Martin becomes CEO14
  15. Sep 20, 2016New chief executive Nathan Stasko becomes CEO15

Calendar

When it reported results

  1. May 15, 2023Reported quarterly or annual results49
  2. Mar 30, 2023Reported quarterly or annual results50
  3. Mar 7, 2023Reported quarterly or annual results51
  4. Nov 14, 2022Reported quarterly or annual results52
  5. Aug 11, 2022Reported quarterly or annual results53
  6. May 16, 2022Reported quarterly or annual results54
  7. Nov 10, 2021Reported quarterly or annual results55

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

117 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 41 major events, 26 insider forms, 43 other. The latest 20:

  1. May 1, 2024EFFECT EDGAR
  2. May 1, 2024EFFECT EDGAR
  3. May 1, 2024EFFECT EDGAR
  4. May 1, 2024EFFECT EDGAR
  5. May 1, 2024EFFECT EDGAR
  6. May 1, 2024EFFECT EDGAR
  7. May 1, 2024EFFECT EDGAR
  8. May 1, 2024EFFECT EDGAR
  9. May 1, 2024POS AM EDGAR
  10. May 1, 2024POS AM EDGAR
  11. May 1, 2024POS AM EDGAR
  12. May 1, 2024POS AM EDGAR
  13. May 1, 2024POS AM EDGAR
  14. May 1, 2024POS AM EDGAR
  15. May 1, 2024POS AM EDGAR
  16. May 1, 2024POS AM EDGAR
  17. May 1, 20248-K EDGAR
  18. Mar 25, 20248-K EDGAR
  19. Feb 26, 20248-K EDGAR
  20. Jan 30, 20248-K EDGAR

The 117 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

8 open-market trades by officers, directors and large owners since October 2021: 7 buys and 1 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 27, 2023SANDERS MACHELLEDirectorSale11,553$0.41$4.7KForm 4
Apr 7, 2022BIERMAN JAMES LDirectorBuy1,000$3.45$3.5KForm 4
Mar 28, 2022BIERMAN JAMES LDirectorBuy1,000$3.45$3.5KForm 4
Mar 25, 2022BIERMAN JAMES LDirectorBuy2,000$3.55$7.1KForm 4
Mar 18, 2022PALMOUR JOHN WDirectorBuy10,000$3.64$36.4KForm 4
Mar 18, 2022GAY JOHN M.Chief Financial OfficerBuy1,000$3.50$3.5KForm 4
Mar 17, 2022PALMOUR JOHN WDirectorBuy5,000$3.34$16.7KForm 4
Mar 16, 2022PALMOUR JOHN WDirectorBuy5,000$3.34$16.7KForm 4

From Forms 4 filed with the SEC.

SEC filer profile

How NVN Liquidation, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARNVN Liquidation, Inc.1
  • CIK0001467154
  • Employer ID (EIN)20-44276821
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business addressP.O. Box 64, Pittsboro, NC 273121
  • Phone919-485-80801
  • Shares outstanding28,015,371 as of May 5, 202311
  • Public float$49.3M as of Jun 30, 20223
  • On EDGAR sinceJul 2, 20091
  • Filings446 in all: 4 (126), 8-K (113), 3 (25), 10-Q (20), EFFECT (13), 424B5 (12), CORRESP (12), CT ORDER (12)1
    All 40 form types

    UPLOAD (11), POS AM (8), 10-K (7), DEF 14A (7), DEFA14A (7), SC 13D/A (7), SC 13G (7), D (6), D/A (6), S-8 (6), 424B3 (5), SC 13G/A (4), PRE 14A (3), S-3 (3), SC 13D (3), 10-K/A (2), DRS/A (2), DRSLTR (2), S-1 (2), S-1/A (2), S-3/A (2), 144 (1), 25-NSE (1), 424B4 (1), 8-A12B (1), 8-K/A (1), ARS (1), CERTNAS (1), DRS (1), FWP (1), NT 10-Q (1), PRER14A (1)

  • Latest filingsAnnual report (10-K) Mar 30, 2023
    Quarterly report (10-Q) May 15, 2023
    Proxy statement (DEF 14A) Apr 27, 2023
    Latest 8-K (8-K) May 1, 2024

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55